Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-Year Followup Data From the Italian Registry

Journal of Rheumatology - Canada
doi 10.3899/jrheum.120583
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Journal of Rheumatology

Related search

Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated With Juvenile Idiopathic Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2018English

Efficacy of Adalimumab in a Patient With Juvenile Idiopathic Arthritis and Uveitis

Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child HealthPediatricsPerinatology
2012English

Juvenile Idiopathic Arthritis and Uveitis: The Classification Conundrum

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2000English

Efficacy of Abatacept Therapy in a Patient With Juvenile Idiopathic Arthritis and Bilateral Uveitis

Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child HealthPediatricsPerinatology
2016English

Idiopathic Neutropenia of Infancy: Data From the Italian Neutropenia Registry

American Journal of Hematology
Hematology
2018English

Infliximab Therapy for Refractory Uveitis: 2-Year Results of a Prospective Trial

Archives of Ophthalmology
2009English

Cost-Utility Analysis of Infliximab and Adalimumab for Refractory Ulcerative Colitis

Cost Effectiveness and Resource Allocation
Health Policy
2009English

The Experience of Successful Use of Adalimumab in a Patient With Juvenile Arthritis Associated With Enthesitis and Uveitis

Pediatric pharmacology
2017English

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy